7044066 and Email: g.verjans@erasmusmc.nl † DPD, WJDO and TS contributed equally as first authors and ‡ GMGMV and JB as last authors. virus progeny 12, 13 . By contrast VZV gene expression during latency remains poorly defined 6, 8, [14] [15] [16] . A lack of appropriate animal 17 and in vitro 18,19 models has led to VZV latency being studied in naturally infected human TGs recovered at post-mortem. Using PCR primers targeting all canonical VZV genes, only ORF63 is occasionally detected in TGs with PMI <9 hrs 8 , whereas multiple virus transcripts of different kinetic classes are observed in human TGs with PMI >9 hrs 6, 8, 15 . Moreover, reports of viral protein detection by immunohistochemistry (IHC) have been largely attributed to the presence of non-VZV antibodies 16 . The lytic VZV gene ORF63, although conserved is not expressed by other latent αHVs and does not share the characteristics of other canonical αHV latency transcripts.
During primary infection, neurotropic alphaherpesviruses (αHVs) gain access to neurons in sensory and cranial ganglia establishing lifelong latent infection from which they can later reactivate to cause debilitating disease 1 . For most αHVs, including the best-studied herpes simplex type 1 ( HSV-1), viral latency is characterized by expression of a single or restricted set of transcripts that map antisense to the open reading frame (ORF) homologous to the major HSV immediate early viral transactivator, ICP0 2 . These latency transcripts, either directly or through encoded miRNAs or proteins, repress expression of the ICP0 orthologues [3] [4] [5] . The exception is varicella-zoster virus (VZV), an αHV which infects over 90% of adults and for which neither a canonical latency transcript 1,6-8 nor a putative mechanism for repressing lytic transcription during latency have been identified. Here, we describe the discovery and functional characterization of a VZV latency transcript (VLT), that maps antisense to VZV ORF 61 (the VZV ICP0 homologue 9, 10 ), and which is consistently expressed in neurons of latently infected human trigeminal ganglia (TG). VLT encodes a protein with late kinetics during lytic VZV infection in vitro and in zoster skin lesions. Whereas multiple alternatively spliced VLT isoforms are expressed during lytic VZV infection, a single unique VLT isoform that specifically suppresses ORF61 gene expression predominates in latently VZV-infected human TG. The discovery of VLT directly unifies the latent VZV transcription program with those of bettercharacterized αHVs, removing longstanding barriers to understanding VZV latency and paving the way for research into the development of vaccines that do not establish latency or reactivate, and drugs that eradicate latent VZV.
Primary VZV infection typically causes varicella (chickenpox), establishes a lifelong persistent infection in ganglia and reactivates in about one-third of latently infected individuals to cause herpes zoster (shingles), often accompanied by multiple serious neurological sequelae 11 . Like other herpesviruses, lytic VZV infection is characterised by full viral gene expression occurring with temporally linked immediate-early (IE), early (E) and late (L) kinetics to generate infectious they derive, but no other viral transcripts ( Supplementary Figs. 3 and 4) . The latency-associated miRNAs (mir-H2, mir-H3, mir-H4, mir-H6, mir-H7 and mir-H14) 5 were also detected in three TGs (donors 1, 3 and 8) selected for and analysed by miRNA sequencing of unenriched RNA libraries ( Supplementary Fig. 5 ). These data illustrate the high specificity and sensitivity of our target-enriched RNA-seq methodology and clearly demonstrate that the HSV-1 latency transcriptome in human TG is limited to the LATs and encoded miRNAs.
While no VZV transcripts could be identified in non-enriched TG RNA samples ( Supplementary Fig. 6 ), enrichment for VZV sequences in polyadenylated RNA revealed the presence of a novel 496-nucleotide multi-exon transcript expressed partially antisense to VZV ORF61 in all seven TGs analysed (donors 1-7; Fig. 1 , Supplementary Figs. 6 and 7, Supplementary Tables 1 and 2 ). Manual inspection of the VZV sequence read data, combined with de novo transcript reconstruction, revealed five distinct exons ( Fig. 1 and Supplementary   Fig. 8a ), two of which encode cleavage factor I-binding motifs (TGTA), while the most 3' exon contained a canonical polyadenylation signal site (AAUAAA) ( Supplementary Fig. 8b ). We term this novel spliced transcript the VZV latency transcript (VLT). Except for ORF63 transcripts detected in six of seven TGs (donors 2 -7) , no other VZV transcripts ( Fig. 1b and Supplementary   Fig. 7 ) or miRNAs were detected in human TGs (data not shown). VLT was also transcribed in lytically VZV-infected ARPE-19 cells ( Fig. 1b and Supplementary Fig. 7 ), enabling rapid amplification of cDNA ends (RACE) to confirm 5' and 3' transcript boundaries. Unlike the single VLT isoform detected in latently VZV-infected human TG ( Fig. 2a ), gene transcription from the VLT locus appears extremely complex during lytic VZV infection, with additional upstream exons or alternative splicing in exons 3 and 4 ( Fig. 2b) . RT-qPCR did not detect any of the three most abundant lytic VLT isoforms (each of which uses a different upstream exon) in latently VZVinfected TGs (Fig. 2c ). Neither were additional upstream exons or alternative splicing of exons 3 and/or 4 evident in human TG-derived VZV RNA from re-examination of the RNA-seq data.
Thus, a unique VLT isoform is selectively expressed in latently VZV-infected human TG with short PMI.
To confirm that VLT expression is a general feature of VZV latency, we analysed TG specimens from 18 individuals (donors 1-18, Supplementary Table 1 ) for the presence of VZV and HSV-1 DNA and transcripts by qPCR and reverse transcriptase-qPCR (RT-qPCR). Thirteen TG were co-infected with VZV and HSV-1, while the remaining TG contained only VZV (donors 10 and 12) or HSV-1 (donors 16 -18) , (Supplementary Table 1 ). Fourteen of 15 (93%) VZV nucleic acid-positive (VZV POS ) TGs expressed VLT and 9 of 15 (60%) VZV POS TGs coexpressed ORF63 mRNA at lower levels relative to VLT ( Fig. 2d, Supplementary Fig. 9a and Supplementary Table 1 ). VLT levels correlated significantly with ORF63 transcript levels ( Fig. 2e and Supplementary Fig. 9b ), but not with VZV DNA load or PMI excluding the possibility of viral reactivation after death (Supplementary Figs. 9c and d) 8 .
Next, we investigated the expression and localization of VLT, and as a control VZV ORF63, in latently VZV-infected TGs (n=12) and two VZV naïve foetal dorsal root ganglia (DRG) by in situ hybridization (ISH). VLT and ORF63 transcripts were localized to both the neuronal nucleus and cytoplasm of distinct neurons in latently VZV-infected TG, but not in uninfected DRG ( Fig. 2f -i, Supplementary Figs. 10 and 11). More TG neurons expressed VLT (0.49 ± 0.20%; mean ± SD) than ORF63 transcript (0.36 ± 0.16%) ( Fig. 2f ). RNase but not DNase treatment abolished ORF63-and VLT-specific ISH staining ( Supplementary Fig. 10 ), confirming detection of VZV transcripts and not viral genomic DNA. Although previous reports suggest that TG neurons are latently infected by VZV and HSV-1 at similar frequencies 23 , both Table 1 , Supplementary Fig. 11 ) revealed a much higher abundance and prevalence of HSV-1 LAT compared to VLT and VZV ORF63 RNA in human TG specimens. 6 In silico translation of the VLT isoform expressed in human TG predicted a 137-amino acid protein (pVLT), with a start codon and polyadenylation site/stop codon in exons 2 and 5, respectively ( Supplementary Fig. 8b ). A polyclonal pVLT-specific antibody, generated against the first 19 N-terminal residues of pVLT, confirmed pVLT expression in the nucleus and cytoplasm of VLT-transfected cells and its predominantly nuclear expression in lytically VZVinfected ARPE-19 cells ( Fig. 3a and b , Supplementary Figs. 8c and 12 ). In lytically VZV-infected ARPE-19 cells, pVLT co-localized with nuclear-expressed ORF62 protein (IE62), but not with cytoplasmically expressed glycoprotein E ( Fig. 3b, Supplementary Fig. 12 ). The kinetic class of VLT was determined by RT-qPCR in VZV-infected ARPE-19 cells cultured in the presence or absence of phosphonoformic acid (PFA), a broad-spectrum herpesvirus DNA polymerase inhibitor 24 . Whereas no effect on ORF61 (IE gene) and ORF29 (E gene) transcription was observed, ORF49 (leaky-L gene) transcription was markedly reduced in PFA-treated VZVinfected cells (Fig. 3c ). PFA blocked VLT expression completely ( Fig. 3c ), demonstrating that VLT transcription follows a truly late kinetic pattern in vitro. Finally, shingles skin biopsies were assayed for expression of VLT and pVLT. ISH revealed VLT expression throughout the affected epidermis and dermis surrounding skin vesicles ( Fig. 3d ), while IHC analyses of consecutive sections for VZV ORF63 protein (IE63) and pVLT indicated co-expression in the same skin areas, but not in healthy control skin ( Fig. 3e, Supplementary Fig. 13 ). Neither pVLT-nor IE63specific IHC signal was detected in latently VZV-infected human TG sections (data not shown).
RT-qPCR and ISH (Supplementary
Because VLT is partially antisense to VZV gene ORF61, a major viral transactivator and αHV ICP0 homologue 9 , we tested whether VLT repressed expression of ORF61 in VLTtransfected ARPE-19 cells. VLT expression significantly reduced ORF61, but not ORF62 and ORF63 transcript levels, in cells co-transfected with all four VZV genes ( Fig. 4a ). Western blot analysis confirmed that VLT diminishes IE61 but not IE62, IE63 and α-tubulin protein abundance in co-transfected cells (Fig. 4b ). Mutation of the pVLT start codon from ATG to ATA ( Supplementary Fig. 8b ) resulted in loss of pVLT expression in co-transfected ARPE-19 cells, but did not abolish the inhibitory effect of VLT on ORF61 transcript and protein (IE61) expression in co-transfected cells ( Fig. 4b and c, Supplementary Fig. 14) . The data implicate VLT, but not pVLT, in the selective repression of VZV ORF61 gene expression.
In this study, we identified a novel and unique, spliced VZV transcript, VLT, which is consistently and selectively expressed in latently VZV-infected human TG neurons. The VLT locus, including splice donor/acceptor sites and pVLT coding sequence, is highly conserved among wild-type and vaccine strains of VZV ( Supplementary Table 4 ). A feature shared between well-characterized latency transcripts of other αHVs, notably HSV-1 and bovine herpesvirus 1, is their ability to encode repressive miRNAs 5, 25 . However, consistent with previous analyses of human TG 26 , we found no evidence of miRNAs encoded within VLT or the wider viral genome. In further contrast to other αHVs, latent VZV also transcribes ORF63 in a subset of latently infected TGs, suggesting a role for this gene in latency or early reactivation.
We also find no evidence for expression of other VZV genes during latent infection. Moreover, unlike HSV-1 LAT, VLT encodes a protein that is expressed with true late kinetics in lytically VZV-infected cells in vitro and in shingles skin lesions. Whereas the function of pVLT remains unclear, we showed that VLT specifically suppresses expression of VZV IE61, a homolog of HSV-1 ICP0 and a promiscuous transactivator of lytic viral promotors 10 . Although VZV disease is now much reduced due to effective vaccines 27-29 , latent persistence of the VZV vOka vaccine strain, that like wild-type VZV can reactivate later in life, will necessitate continuing lifelong surveillance and potentially revaccination 30 . With our findings the field is now better positioned to understand the molecular pathways by which VZV establishes and maintains latency. This information will be critical for the future development of measures to enhance control of this ubiquitous human herpesvirus.
.
20.
Depledge Dis. 197, S165-S169 (2008). Table 1 ), using primers/probes spanning VLT exons 3→4, A→1, B→1 and C→1 (Supplementary Table 5 ). Data represent mean (± standard error mean; SEM) relative transcript levels normalized to β-actin RNA abundance. nd, not detected. Table 1 ). (coordinates refer to VZV reference strain Dumas; NC_001348.1) ( Supplementary Table 3 ). b,
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The VLT mRNA sequence including the 5' untranslated region; start and stop codons are cells transiently transfected with plasmids encoding FLAG-tagged VLT (VLT ATG ), mutated VLT lacking a start codon (VLT ATA ) or empty control plasmid, in combination with plasmids encoding ORF61, ORF62 and ORF63. Cells were stained using antibodies to FLAG (red) and VLT protein (pVLT; green); nuclei were stained with Hoechst (blue). Magnification: 600X. Bars=20 µm. Supplementary Table 1 VLTup22ecoF  VZV VLT  ACC-GAA-TTC-CAC-CGT-TGC-CTT-TAC-TAG-CAG  none  none   VLT-FLAGxhoR  VZV VLT  ACC-CTC-GAG-TTA-CTT-GTC-GTC-ATC-GTC-TTT-GTA-GTC-TTT-ACG-GGT-ATT-ACA-GGG  none  none   VLT-G3A  VZV VLT  TAT-TTG-CAG-AGC-AGG-ATA-CCC-CGG-TTA-CTC-CGA  none  none   ORF61up20ecoF  VZV ORF61  ACC-GAA-TTC-GAA-TAC-AGC-CAG-TTG-TTA-CC  none  none   ORF61salR  VZV 
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Materials and Methods
Human clinical specimens
Human trigeminal ganglia (TG), obtained at 6:01 h ± 1:47 hr (average ± SD) after death, were provided by the Netherlands Brain Bank (Amsterdam, the Netherlands) (Supplementary Table   1 ). All individuals provided prior written informed consent for brain autopsy and the use of were cultured on ARPE-19 cells as described [32] [33] [34] . All cell cultures and virus infections were performed in a humidified CO 2 incubator at 37°C.
Cells and viruses
Nucleic acid extraction from human TG
Approximately one-fifth of snap-frozen human TG was mechanically dispersed and used for DNA isolation, while four-fifths of the same specimen was used for RNA isolation. DNA extraction was performed using the QIAamp DNA kit (Qiagen) according to the manufacturer's instructions. For RNA isolation, samples were homogenized in TRIzol (Invitrogen), mixed vigorously with 200 µL chloroform and centrifuged for 15 min at 12,000xg at 4°C. RNA was isolated from the aqueous phase using the RNeasy Mini Kit, including on-column DNase I treatment (Qiagen). DNA and RNA concentration and integrity were analysed using a Qubit Flourometer (ThermoFisher).
RNA extraction from lytic VZV and HSV-1 infections
ARPE-19 cells were infected with VZV strain EMC-1 by co-cultivation VZV-infected or uninfected cells at a 1:8 cell ratio and harvested in 1 mL TRIzol at 72 hrs post-infection (hpi).
Alternatively, semi-confluent ARPE-19 cell layers (75 cm 2 flask) were infected with HSV-1 strain F at a multiplicity of infection (MOI) of 1 and harvested in 1 mL TRIzol at 24 hpi. RNA isolated as described above was subjected to additional DNase treatment using the TURBO DNA-free kit according to the manufacturer's instructions (Ambion).
RNASeq library preparation and sequencing
Four micrograms of total RNA was used as input for the SureSelectXT RNA Target Enrichment protocol (Agilent Technologies G9691 version D0). Here, each sample was either enriched for polyadenylated mRNA (captured by oligo-dT beads, as described by the SureSelect XT protocol) or underwent rRNA-depletion using a NEBNext® rRNA Depletion Kit [Human/Mouse/Rat] (New England Biolabs) according to manufacturer's instructions.
Subsequent to either procedure, captured/remaining RNAs were transcribed to produce cDNA.
Fragmentation, cDNA second strand synthesis, end repair, A-tailing and adapter ligation were performed as described in the enrichment protocol. Hybridisation was performed using a modified strategy 20,21 that incorporated custom-designed SureSelect RNA bait sets for both VZV and HSV-1 in the same reaction at reduced concentration (1:10). Bait sets for VZV and HSV-1 were designed at 12x tiling (i.e. each base position in the genome was covered by 12 distinct 120-mer bait sequences) using custom in-house scripts and are available from the authors upon request. Hybridisation for 24 hrs at 65°C was followed by post-capture washing and optimised PCR-based library indexing (12 cycles for RNA obtained from lytically-infected cultures, 18 cycles for RNA obtained from TGs). Libraries generated from VZV-and HSV-1-infected ARPE-19 cells were multiplexed and sequenced using a 75 cycle V2 high-output kit. Subsequently, three TG were multiplexed sequenced using a 150 cycle V2 mid-output kit followed by a further four TG multiplexed and sequenced using a 300 cycle V2 high-output kit. The decision to use increasing read lengths was informed by the initial discovery of VLT and the desire to better characterise intron splicing.
Transcriptome mapping and de novo transcript reconstruction
Sequence run data were de-multiplexed using bcl2fastq2 v2.17 under stringent conditions (-barcode mismatches 0) and yielded between ~ 31,000,000 -107,700,00p0 paired-end reads per sample. Individual sequence datasets were trimmed using TrimGalore software To confirm that enrichment for viral nucleic acids did not bias relative levels of viral gene transcription, transcripts per million (TPM) counts were generated using featurecounts (subread package 38, 39 ) and visualised using scatter plots. High correlation (R 2 0.9252 -0.9678) between enriched and unenriched transcriptomes were observed for both HSV-1 (n=2 biological replicates) and VZV (n=1), as shown in Supplementary Figure S1 .
For de novo transcript reconstruction, VZV-specific mapping read pairs for each TG were extracted from BAM files and converted to raw fastq format for input into Trinity 40 . Trinity enables transcript reconstruction and, while limited in this case by the scarcity of VZV reads, was able to merge overlapping reads to produce transcript isoforms that, when mapped to the VZV reference genome using BBmap, spanned the four major introns observed in the VZV latency transcript.
MicroRNA sequencing (miRNASeq) and qPCR profiling miRNASeq libraries were prepared from 1 µg of total RNA, isolated from human TG and lytically VZV-and HSV-1-infected ARPE-19 cells, using the NEBNext ® small RNA Library Prep Set for Illumina ® according to manufacturer's instructions. Libraries underwent 75bp single-end sequencing using an Illumina NextSeq prior to demultiplexing (as outlined above). Sequence reads were adaptor-trimmed using TrimGalore and size selected using BBduk (provided with BBmap) so that only sequence reads between 17-26 bases in length were retained. These were cDNA synthesis and qPCR cDNA synthesis was performed as described 8 Table 5 ). Commercially quantified VZV PCR products were sequenced on the ABI Prism 3130 XL Genetic Analyzer using the BigDye v3.1 Cycle Sequencing Kit (both Applied Biosciences) and M13Fw and M13Rv primers.
Resultant FASTA sequences were aligned the VZV reference genome Dumas using BBmap, as outlined above. Resultant assemblies were inspected alongside RNASeq data using IGV 43 .
In situ hybridisation
To select for VZV and HSV-1 DNA positive TG tissue areas, DNA was isolated from three consecutive 5 µm FFPE tissue sections using the QIAamp DNA FFPE Tissue Kit and analysed by the respective virus-specific qPCR assays. Subsequently, viral DNA POS FFPE TG specimens, human fetal DRG (negative control) and human zoster skin biopsies were analysed by in situ hybridization (ISH) using the RNAScope 2.0 red kit (Advanced Cell Diagnostics) according to the manufacturer's instructions. In brief, deparaffinised 5 µm tissue sections were incubated with probes designed to cover VZV ORF63 and VLT exons 2 to 5. The probes for the human transcript POLR2A and ubiquitin C (UBC) were used as positive controls and probes specific for the bacterial transcript DAPB were used as negative controls. All probes were designed and produced by Advanced Cell Diagnostics. FastRed was used as substrate to visualize the ISH signal and stained slides were counterstained with haematoxylin and mounted in Ecomount (Biocare Medical). In some experiments, TG sections were incubated with DNase I (Qiagen) or RNAse [Ribonuclease A (25µg/mL) + T1 (25 units/mL; both Thermo Fisher Scientific) diluted in 1xTBS-t], after pre-treatment step #3 for 1 hr at 40°C. To determine the ratio of VZV and HSV-1 transcript expressing TG neurons, slides were scanned using the Nanozoomer 2.0 HT (Hamamatsu) and scored in Adobe Photoshop CS6 (Adobe). Twelve TG from distinct donors were analysed for VZV ORF63 and VLT and 10 TG for HSV-1 LAT, with on average 664 neurons/section (range: 420-1561) and 1-2 sections per TG. Two herpes zoster skin biopsies from distinct donors were analysed with 2-3 sections per donor for each staining.
Determination of kinetic class of VZV transcripts
ARPE-19 cells (2x10 5 cells) were infected with pOka VZV cell-free virus (10 3 plaque forming units) with and without phosphonoformic acid (PFA; 200 µg/mL) for 24 hrs at 37°C. Total RNA was isolated from cells using NucleoSpin RNA in combination with the NucleoSpin RNA/DNA buffer set (Macherey-Nagel) according to the manufacturer's instructions. Binding DNA was first eliminated from the column in 100 µL DNA elution buffer, the column was treated with recombinant DNase I (5 units/100 µL; Roche Diagnostics) for 1 hr at 37°C and finally RNA was eluted in 60 µL nuclease free water. cDNA was synthesized with 10.4 µL of total RNA and anchored oligo(dT) 18 primer in a 20 µL reaction using the Transcriptor High Fidelity cDNA synthesis kit (Roche Diagnostics). qPCR following a dissociation curve analysis was performed as described previously 18 using SYBR Select Master Mix in a StepOnePlus Real-time PCR system (Thermo Fisher Scientific). The primer sets for β-actin, and VZV ORF61 and ORF49 genes were described previously 18 and primers for VZV ORF29 (ORF29F2381 and ORF29R2440) and VLT (VLTexon1F and VLTexon2R) are presented in Supplementary Table   5 .
Plasmid construction
The VLT coding sequence (102,468 -104,818, excluding introns indicated in Supplementary   Table 3 ), ORF61 and ORF63 coding sequences were amplified by PCR of cDNA prepared from pOka-infected MeWo cells showing >80% cytopathic effect using the primer sets VLTup22ecoF and VLT-FLAGxhoR, ORF61up20ecoF and ORF61SalR, or ORF63up20ecoF and ORF63xhoR, respectively (Supplementary Table 5 ). Products were digested with EcoRI and XhoI (VLT and ORF63), or EcoRI and SalI (ORF61), restriction enzymes and subsequently cloned into pCAGGS-MCS-puro (CAG.Empty) via EcoRI and XhoI sites. The resulting VLT, ORF61 and ORF63 expressing plasmids were named as follows: CAG.VLT-FLAG, CAG.ORF61 and CAG.ORF63. The CAG.VLT(ATA)-FLAG plasmid, in which the ATG start codon of VLT ORF the manufacturer's recommendation based on the CAG.VLT-FLAG. All primers used to construct VZV gene expression plasmids are listed in Supplementary Table 5 . The pCAGGS plasmid (14) was generous gift from Dr. Jun-ichi Miyazaki (Osaka University, Japan). The pcDNA.ORF62 was a generous gift from Dr. Yasuyuki Gomi (Research Foundation for Microbial Diseases, Osaka University).
Generation of rabbit anti-pVLT and -IE63 antibodies
Anti-VLT protein (pVLT) antibody was generated by Sigma-Aldrich by immunizing a rabbit with a synthetic peptide encoding the first 19 amino acids of pVLT (MPRLLRDRIAGIPNRVRTY - Fig.   S3 ). The antibody was purified using pVLT peptide conjugated NHS (N-hydroxysuccinimide)activated sepharose (GE Healthcare Life Sciences). Anti-IE63 antibody was also generated by Sigma-Aldrich by immunizing a rabbit with GST-IE63 protein as described for anti-IE61 antibody 44 . Briefly, GST-IE63 protein was expressed in and purified from E. coli BL21 transformed with pGEX-IE63, in which the entire DNA fragment except the first ATG (i.e. ORF63 nucleotide positions 4 -837) was cloned into pGEX6P-1 bacterial expression vector (GE Healthcare). The anti-IE63 antibody was purified using GST-conjugated NHS-activated sepharose for depleting anti-GST antibody and GST-IE63-conjugated NHS-activated sepharose.
Immunofluorescent staining and confocal microscopy of cells
The following primary mouse monoclonal antibodies directed to the indicated proteins were used: VZV IE62 (clone 2-B; generous gift from Dr. Yasuyuki Gomi of Research Foundation for Microbial Diseases, Osaka University) and VZV glycoprotein E (clone 9) 45, 46 and anti-DYK
